![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Buschmann, Christina; Unverdorben, Laura; Knabl, Julia; Hutter, Stefan; Meister, Sarah; Beyer, Susanne; Burgmann, Maximiliane; Zati zehni, Alaleh; Schmoeckel, Elisa 
ORCID: https://orcid.org/0000-0001-7199-3837; Kessler, Mirjana; Jeschke, Udo ORCID: https://orcid.org/0000-0003-2623-3235; Eggersmann, Tanja K.; Mahner, Sven ORCID: https://orcid.org/0000-0002-2224-5709; Kolben, Thomas und Ganster, Franziska
(2024):
Placental expression of inflammatory Galectin-12 is associated with gestational diabetes.
In: Journal of Reproductive Immunology, Bd. 163, 104240
[PDF, 6MB]
ORCID: https://orcid.org/0000-0001-7199-3837; Kessler, Mirjana; Jeschke, Udo ORCID: https://orcid.org/0000-0003-2623-3235; Eggersmann, Tanja K.; Mahner, Sven ORCID: https://orcid.org/0000-0002-2224-5709; Kolben, Thomas und Ganster, Franziska
(2024):
Placental expression of inflammatory Galectin-12 is associated with gestational diabetes.
In: Journal of Reproductive Immunology, Bd. 163, 104240
[PDF, 6MB]
Reichenbach, Juliane; Fraungruber, Patricia; Mayr, Doris; Buschmann, Christina; Kraus, Fabian B. T.; Topalov, Nicole Elisabeth; Chelariu-Raicu, Anca; Kolben, Thomas; Burges, Alexander; Mahner, Sven ORCID: https://orcid.org/0000-0002-2224-5709; Kessler, Mirjana; Jeschke, Udo; Czogalla, Bastian und Trillsch, Fabian ORCID: https://orcid.org/0000-0002-1860-4350
(2023):
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 11: S. 8719-8728
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-2224-5709; Kessler, Mirjana; Jeschke, Udo; Czogalla, Bastian und Trillsch, Fabian ORCID: https://orcid.org/0000-0002-1860-4350
(2023):
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 11: S. 8719-8728
[PDF, 2MB]
Badmann, Susann; Mayr, Doris; Schmoeckel, Elisa; Hester, Anna; Buschmann, Christina; Beyer, Susanne; Kolben, Thomas; Kraus, Fabian; Chelariu-Raicu, Anca; Burges, Alexander; Mahner, Sven; Jeschke, Udo; Trillsch, Fabian und Czogalla, Bastian
(3. Februar 2022):
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.
In: Scientific Reports, Bd. 12
[PDF, 3MB]
Keilmann, Lucia; Beyer, Susanne; Meister, Sarah; Jegen, Magdalena; Buschmann, Christina; Schröder, Lennard; Keckstein, Simon; Jeschke, Udo; Burges, Alexander; Mahner, Sven; Trillsch, Fabian; Kost, Bernd und Kolben, Thomas
(2022):
Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany.
In: Archives of Gynecology and Obstetrics, Bd. 307, Nr. 1: S. 129-137
[PDF, 686kB]
Kolben, Thomas; Müller, Lena; Meister, Sarah; Keilmann, Lucia; Buschmann, Christina; Trillsch, Fabian; Burges, Alexander; Czogalla, Bastian; Mittler, Sophie; Schmoeckel, Elisa; Corradini, Stefanie; Mahner, Sven; Jeschke, Udo ORCID: https://orcid.org/0000-0003-2623-3235; Kessler, Mirjana und Beyer, Susanne
(2022):
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 148, Nr. 12: S. 3323-3335
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-2623-3235; Kessler, Mirjana und Beyer, Susanne
(2022):
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 148, Nr. 12: S. 3323-3335
[PDF, 2MB]
Beyer, Susanne; Müller, Lena; Mitter, Sophie; Keilmann, Lucia; Meister, Sarah; Buschmann, Christina; Kraus, Fabian; Topalov, Nicole E.; Czogalla, Bastian; Trillsch, Fabian; Burges, Alexander; Mahner, Sven; Schmoeckel, Elisa; Löb, Sanja; Corradini, Stefanie; Kessler, Mirjana; Jeschke, Udo und Kolben, Thomas
(2022):
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer.
In: Journal of Cancer Research and Clinical Oncology
[PDF, 1MB]
Schrader, Svenja; Unverdorben, Laura; Hutter, Stefan; Knabl, Julia; Schmoeckel, Elisa; Meister, Sarah; Zehni, Alaleh Zati; Beyer, Susanne; Vilsmaier, Theresa; Mahner, Sven; Jeschke, Udo; Kolben, Thomas; Buschmann, Christina und Keilmann, Lucia
(2022):
Overexpression of galectin-4 in placentas of women with gestational diabetes.
In: Journal of Reproductive Immunology, Bd. 151, 103629
Nguyen-Strauli, Bich Doan; Baum, Joanna; Meyer-Wilmes, Philipp; Kreklau, Anne; Buschmann, Christina; El Ouardi, Nabila; Fotopoulou, Christina; Hummel, Michael; Chekerov, Radoslav; Braicu, Elena; Sehouli, Jalid und Pietzner, Klaus
(2022):
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynakologische Onkologie intergroup analysis.
In: International Journal of Gynecological Cancer, Bd. 32, Nr. 10: S. 1297-1302